Evidence map›Paper›PMID 36582631›Full record

ArticleHealth science reports2023

Effect of COVID-19 infection on sex hormone levels in hospitalized patients: A prospective longitudinal study in Iran.

Poorandokht Afshari, Mehrnoosh Zakerkish, Parvin Abedi, Maryam Beheshtinasab, Elham Maraghi, Hossein Meghdadi

Open access · goldAbstract read
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Implications of Dysnatremia and Endocrine Disturbances in COVID-19 Patients.International journal of molecular sciences · 2024
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Poorandokht AfshariMidwifery Department Reproductive Health Promotion Research Center, Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.
Mehrnoosh ZakerkishMedicine School, Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.
Parvin AbediMidwifery Department Menopause Andropause Research Center, Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.ORCID 0000-0002-6980-0693
Maryam BeheshtinasabReproductive Health Promotion Research Center, Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.
Elham MaraghiBiostatistics Department Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.
Hossein MeghdadiAhvaz Jundishapur University of Medical Sciences Ahvaz Iran.
Ahvaz Jundishapur University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aimed to evaluate the levels of sex hormones in patients with COVID-19 in Ahvaz, Iran. Methods: A prospective longitudinal study was conducted at Razi hospital, Ahvaz, Iran, from July 2020 to Febuary 2021. The levels of sex hormones including estradiol, progesterone, luteinizing hormone (LH), follicle stimulating hormone (FSH), and total and free testosterone were measured in 162 patients with COVID-19 infection during hospitalization and 1 month after discharge. A demographic questionnaire and a checklist were used to collect the data. Mann-Whitney Results: Sex hormones were assessed in 162 patients at baseline; however, a month after discharge, only 69 patients provided consent for assessment, and 9 had passed away. The estradiol level was 407.70 ± 623.37 and 213.78 ± 407.17 pg/ml in female patients with severe and moderate diseases at baseline, respectively which reduced to 195.33 ± 380.04 and 58.20 ± 39.45 pg/ml after discharge ( Conclusion: Our findings showed that the level of estradiol in female patients increased significantly while the level of testosterone in male patients decreased during the active phase of infection. Due to the attrition of patients in the follow-up period, more studies are needed to confirm these results.

Indexed as

COVID‐19estradiolfollicle stimulating hormoneluteinizing hormoneprogesterone

Identifiers

PMID36582631
PMCPMC9789677
OpenAlexW4312222826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.